Figure 2. . Network plots of the endoscopic healing rates at (A & B) 4 and 8 weeks and (C) treatment-emergent adverse events.

The size of each node is corresponding to the number of patients, and the thickness of each solid line between two nodes is corresponding to the number of direct comparisons.

PPI: Proton pump inhibitors; VPZ5: Vonoprazan 5 mg; VPZ10: Vonoprazan 10 mg; VPZ20: Vonoprazan 20 mg; VPZ40: Vonoprazan 40 mg; TEAEs: Treatment-emergent adverse events.